mavacamten

PRINCETON, N.J., USA, March 29, 2026 Bristol Myers Squibb has announced positive Phase 3 results from the SCOUT-HCM trial...

PRINCETON, NEW JERSEY, March 23, 2026 Bristol Myers Squibb has unveiled new clinical and real-world data for Camzyos (mavacamten)...

Princeton, N.J., November 4, 2025 – Bristol Myers Squibb (NYSE: BMY) announced a major scientific milestone with the presentation...